Recent Findings in the Regulation of Programmed Death Ligand 1 Expression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent Findings in the Regulation of Programmed Death Ligand 1 Expression

Published:2019-06-14 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Shen Xiangfeng,Zhang Lihong,Li Jicheng,Li Yulin,Wang Yishu,Xu Zhi-Xiang

Funder

National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference368 articles.

1. Nivolumab in previously untreated melanoma without BRAF mutation;Robert;N Engl J Med.,2015

2. Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial;Weber;Lancet Oncol.,2015

3. Pembrolizumab for the treatment of non-small-cell lung cancer;Garon;N Engl J Med.,2015

4. Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer;Antonia;N Engl J Med.,2017

5. Updated efficacy analysis including secondary population results for OAK: a randomized phase III study of atezolizumab vs docetaxel in patients with previously treated advanced non-small cell lung cancer;Fehrenbacher;J Thorac Oncol.,2018

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of ncRNAs and exosomes in the development and progression of endometrial cancer;Frontiers in Oncology;2024-08-12

2. Receptor-Targeted Nanomedicine for Cancer Therapy;Receptors;2024-07-03

3. Targeted protein degradation combined with PET imaging reveals the role of host PD-L1 in determining anti-PD-1 therapy efficacy;European Journal of Nuclear Medicine and Molecular Imaging;2024-06-24

4. Tissue fibroblasts are versatile immune regulators: An evaluation of their impact on the aging process;Ageing Research Reviews;2024-06

5. Polymer-based antibody mimetics (iBodies) target human PD-L1 and function as a potent immune checkpoint blocker;Journal of Biological Chemistry;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3